Abstract: The present invention is directed to a kit of parts having biological activity, the kit of parts comprising a first target comprising a first protein and a second target comprising a second protein, wherein the first protein and the second protein are suitable to form a heterodimer upon irradiation with UV, visible or infrared light in a first wavelength range or in the dark, which can be reversed upon irradiating the heterodimer with UV, visible or infrared light in a second wavelength range or in the dark, wherein the second wavelength range is different from the first wavelength range, wherein the biological activity consists of triggering both the uptake of DNA, RNA, proteins, or small molecules into a cell which is preferably genetically unmodified, and biological effects, and characterized in that at least one of the first and the second target itself has reduced biological activity as compared with the heterodimer.

Abstract: An undercutting tool for machining an undercut anchoring cut-out into a material, in particular a bone material, has a drive element, which is driveable in rotation about a main axis for application of a driving torque, and a rotatably mounted tool carrier, which has a working end with a working tool and is connectable to the drive element by means of a drive connection. The tool carrier is pivotable from an initial position, in which it extends along the main axis, into an undercutting position, in which it has an angle of inclination relative to the main axis and can be driven with a wobbling movement.

Abstract: A setting assembly for a clamped fixation of a tissue strand, such as a tendon or a band in particular, to a securing recess, which is recessed into a bone, has a clamping element which has a clamping section that tapers along a central axis of the clamping element towards a first end, a recess that is provided on a second end facing away from the first end for passing through the tissue strand, and a tool receiving area that is recessed onto the first end and has a first contact for applying a force acting in a pushing direction and a second contact for applying a force acting in a pulling direction opposite the pushing direction. The setting assembly additionally has an applicator which has an insertion end for releasably connecting to the tool receiving area, the insertion end having a first mating contact which can be placed against the first contact and a second mating contact which can be placed against the second contact means.

Abstract: An anchor arrangement is provided for surgical tissue repair, such as in particular for repair of a meniscus tear, having at least one first anchor and one second anchor, which are movable along a hollow needle for placement on a tissue to be repaired and connected to each other via a seam element. The first anchor and the second anchor each extend between a distal end and a proximal end and form a guide surface on the outside thereof for contacting an inside of a hollow needle at least in part. In addition, there are deflectors on the anchors, via which a torque can be applied at least in part to the anchors during or after setting. At least one of the anchors has at least two anchor sections, which are movable relative to each other and which can be pivoted relative to each other between a folded position, in which the guide surface spans a cross-section deviating from a circular profile, and an unfolded position.

Abstract: An anchor for surgical repair of a tissue, which anchor, for its placement on the tissue to be repaired, is movable along a hollow needle and connectable to a suture element, and it has at least two anchor portions displaceable relative to each other and connected to each other by an axle arrangement, via which the anchor portions are pivotable relative to each other between a retracted position and a deployed position. Provision is made that the axle arrangement has an axle element provided on the first anchor portion and a guide recess provided on the second anchor portion, by which the first anchor portion is held rotatably and linearly displaceably relative to the second anchor portion, and the anchor portions are displaceable from the retracted position to the deployed position by a rotation movement and are displaceable from said deployed position to a rotationally blocked end position by a linear movement.

Abstract: A device (2) for continuous infusions has a housing (4) in which an infusion appliance seat (6) is provided for receiving an infusion appliance (18) with at least one container (22) that can be pressed empty by means of a ram (20), which infusion appliance seat (6) extends along a main axis of extent (AA) from a ram-side end (26) to an outlet-side end (28). The continuous infusion device (2) moreover has an actuator (30) for automatically emptying the infusion appliance (18), a drive (32) for moving a ram abutment/actuation element (24) of the actuator (30), and a control arrangement (72) by means of which a speed of advance of the actuator (30) is adjustable. Provision is made here that the main axis of extent (AA) of the infusion appliance seat (6) has a predetermined relief angle (W) in relation to a support plane (E) of the housing (4), and here the outlet-side end (28) is arranged above the ram-side end (26) of the infusion appliance seat (6).

Abstract: An injection device has a housing in which a syringe can be received that has an injection needle, a receiving chamber, a piston and a piston ram, and a control arrangement for controlled actuation of the syringe during an application procedure that includes at least one puncture stroke, one injection stroke and one return stroke. The control arrangement has an actuation element for applying a drive force to a syringe holder which is movable relative to the housing and on which the receiving chamber can be secured, a ram holder which is movable relative to the housing and on which the piston ram can be secured, and a transmission mechanism by means of which the ram holder can be coupled to the actuation element. Provision is made that the transmission mechanism has a toothed gearing by means of which the ram holder can be driven, according to a relative movement of the actuation element with respect to the housing, and which for this purpose has teeth on the housing.

Abstract: An injection device has a housing, in which a syringe can be held, which has an injection needle, a holding chamber, a plunger tip, and a syringe plunger; and a control assembly for the controlled actuation of the syringe during an application process, which includes at least an insertion stroke, an injection stroke, and a return stroke. The control assembly has an actuation element for receiving a manual driving force, a syringe holder, which can be slid in relation to the housing and to which the holding chamber can be fastened, a plunger holder, which can be slid in relation to the housing and to which the syringe plunger can be fastened, and a transmission device, which has a gearing for coupling the plunger holder to the actuation element, by means of which gearing the plunger holder can be driven in accordance with a motion of the actuation element relative to the housing.

Abstract: An anchor arrangement is provided for surgical tissue repair, such as in particular for repair of a meniscus tear, having at least one first anchor and one second anchor, which are movable along a hollow needle for placement on a tissue to be repaired and connected to each other via a seam element. The first anchor and the second anchor each extend between a distal end and a proximal end and form a guide surface on the outside thereof for contacting an inside of a hollow needle at least in part. In addition, there are deflectors on the anchors, via which a torque can be applied at least in part to the anchors during or after setting. At least one of the anchors has at least two anchor sections, which are movable relative to each other and which can be pivoted relative to each other between a folded position, in which the guide surface spans a cross-section deviating from a circular profile, and an unfolded position.

Abstract: An injection device has a housing in which a syringe can be received that has an injection needle, a receiving chamber, a piston and a piston ram, and a control arrangement for controlled actuation of the syringe during an application procedure that includes at least one puncture stroke, one injection stroke and one return stroke. The control arrangement has an actuation element for applying a drive force to a syringe holder which is movable relative to the housing and on which the receiving chamber can be secured, a ram holder which is movable relative to the housing and on which the piston ram can be secured, and a transmission mechanism by means of which the ram holder can be coupled to the actuation element. Provision is made that the transmission mechanism has a toothed gearing by means of which the ram holder can be driven, according to a relative movement of the actuation element with respect to the housing, and which for this purpose has teeth on the housing.

Abstract: A continuous infusion device with a housing, in which an infusion device can be inserted. The infusion device includes at least one infusion liquid container which can be pressed out; an actuating device for pressing out the infusion device; a drive for moving the actuating device, the drive having a mechanical energy storage device; and a mechanical control arrangement, wherein a speed of the actuating device can be adjusted. The control arrangement has a brake device that provides at least one brake element, which can be braked and is motion-coupled to the drive, and a magnetic member wherein a magnetic field can be generated that applies a brake force to the brake element.

Abstract: The present invention relates to the preparation and use of reversibly PEGylated nanocarriers. The reversibly PEGgylated nanocarrier system comprises an inner core comprising or consisting of a nanoparticle and/or at least one pharmaceutical compound; optionally at least one lipid bilayer on the surface of the inner core; a first ligand bound to the surface of said inner core, or if present, to the surface of the at least one lipid bilayer; a second ligand bound to the first ligand, the second ligand being covalently bound to poly(ethylene glycol) or a derivative thereof. The reversibly PEGgylated nanocarrier system is characterized in that binding of the second ligand to the first ligand is non-covalent and reversible. Pharmaceutical compositions and use of such compounds and compositions in the field of e.g. cancer therapy, gene therapy, inflammatory diseases and pain therapy are also disclosed.

Abstract: A device (2) for continuous infusions has a housing (4) in which an infusion appliance seat (6) is provided for receiving an infusion appliance (18) with at least one container (22) that can be pressed empty by means of a ram (20), which infusion appliance seat (6) extends along, a main axis of extent (AA) from a ram-side end (26) to an outlet-side end (28). The continuous infusion device (2) moreover has an actuator (30) for automatically emptying the infusion appliance (18), a drive (32) for moving a ram abutment/actuation element (24) of the actuator (30), and a control arrangement (72) by means of which a speed of advance of the actuator (30) is adjustable. Provision is made here that the main axis of extent (AA) of the infusion appliance seat (6) has a predetermined relief angle (W) in relation to a support plane (E) of the housing (4), and here the outlet-side end (28) is arranged above the ram-side end (26) of the infusion appliance seat (6).

Abstract: An injection device including a carrier housing in which an injection unit having at least one injection liquid container that can be pressed out can be inserted, and an actuating device which can be driven along an injection direction (R) to activate the injection unit. The actuating device includes a piercing carriage a receptacle for the injection unit, and an injection carriage which can be displaced relative to the piercing carriage. The injection carriage has an actuating plunger for acting on a plunger of the injection unit. The piercing carriage and the injection carriage can be actuated by a force application means at least in order to carry out a piercing stroke and an injection stroke, and a piercing depth (tE) of the injection unit can be set. For this purpose, the receptacle is mounted on the piercing carriage adjustably in the injection direction (R).

Abstract: An injection device (2) comprises a housing (4) in which a receiving chamber (6) is provided for an injection mechanism (8) having an injection fluid container (10) that can be pressed out by means of an injection plunger (12). The injection device (2) further comprises an actuating device (18) that can be driven for automatically pressing out the injection fluid container (10), wherein said actuating device can be displaced between an insertion/removal position outside of the receiving chamber (6) and an injection position within the receiving chamber (6), wherein the actuating device (18) is spaced by a release distance (d) from the receiving chamber (6) in the insertion/removal position. A contact mechanism (22) is provided, by means of which the actuating device (18) can be brought into a stop position in which an actuating stop (26) of the actuating device (18) contacts the injection plunger (12) and in which an injection volume adjustment (28) is automatically actuated.

Abstract: A continuous infusion device with a housing, in which an infusion device can be inserted. The infusion device includes at least one infusion liquid container which can be pressed out; an actuating device for pressing out the infusion device; a drive for moving the actuating device, the drive having a mechanical energy storage device; and a mechanical control arrangement, wherein a speed of the actuating device can be adjusted. The control arrangement has a brake device that provides at least one brake element, which can be braked and is motion-coupled to the drive, and a magnetic member wherein a magnetic field can be generated that applies a brake force to the brake element.

Abstract: The invention relates to a pharmaceutical composition comprising a compound preventing EthR from binding to the ethA promoter, for example a compound of formula 1 wherein R1 is optionally substituted phenyl or optionally substituted pyridyl; R2 (CH2)n wherein n is 1, 2, 3 or 4; R3 is CH3(CH2)m wherein m is 0, 1, 2 or 3; X1 is O, S, NH, N(CH3) or CH2; and X2 is O, S or NH; in particular 2-phenylethyl butyrate, and a thioamide or thiourea of formula 2 wherein R4 is optionally substituted phenyl, optionally substituted pyridyl, optionally substituted indolyl, —NR7R8; or —NH—N?CH—R9; and substituents R5 to R9 have the meanings indicated in the description, in particular ethionamide. The pharmaceutical composition is useful, e.g., in the treatment of multidrug-resistant tuberculosis.

Abstract: The present invention is directed to a bio-functionalized stimulus-responsive dissolvable PEG-hydrogel. This inventive stimulus-responsive dissolvable PEG-hydrogel comprises a matrix of PEG-polymers, which are modified to contain at least one multifunctional fusion protein, the multifunctional fusion protein preferably comprising as components a substrate binding peptide (SBP), preferably a repetitive RGD-binding peptide and/or a ZZ-binding domain, preferably a tag for purification, and at least one N- and/or C-terminal linker. The present invention is furthermore directed to the use of such inventive stimulus-responsive dissolvable PEG-hydrogels in the treatment of lesions, in surgical dressings, for wound treating, for soft and hard tissue regeneration, for the treatment of wounds in the oral cavity, in the field of ophthalmology, in the field of periodontal defects, etc. The invention also describes a method of treatment for such diseases.

Abstract: The invention relates to a pharmaceutical composition comprising a compound of formula (1) wherein R1 is optionally substituted phenyl, optionally substituted pyridyl or optionally substituted indolyl; R2 is (CH2)n wherein n is 0, 1, 2, 3 or 4; R3 is (CH2)mR3A wherein m is 0, 1, 2, 3 or 4, and R3A is methyl, isopropyl, tert-butyl, OCH3, OH, optionally substituted phenoxy, C?CH, C?N, optionally substituted phenyl, furanyl or thienyl; A is a ring containing X1 with the meaning O, S, NH, N(CH3) or CH2; and X2 is O, S or NH; and a compound of formula (2) wherein R4 is optionally substituted phenyl, optionally substituted pyridyl, optionally substituted indolyl, —NR7R8; or —NH—N?CH—R9; and substituents R5 to R9 have the meanings indicated in the description, in particular ethionamide. The pharmaceutical composition is useful, e.g., in the treatment of multidrug-resistant tuberculosis.

Abstract: The invention relates to vectors and mammalian cells in a system useful for switching on or switching off gene expression in response to uric acid. In a particular embodiment the invention relates to a mammalian cell useful in detecting and/or degrading a harmful excess of uric acid comprising (a) a vector comprising a genetic code for the uricase sensor-regulator HucR from Deinococcus radiodurans R1 fused to a transactivation domain or a transrepressor domain; and (b) a vector comprising the corresponding operator sequence hucO from Deinococcus radiodurans R1 specifically binding the bacterial uric acid sensor-regulator HucR, a promoter and a polynucleotide coding for an endogenous or exogenous protein, e.g. a protein interacting with uric acid.